Takeda considers selling Osaka headquarters to fund Shire purchase

Takeda Pharmaceutical Co. is considering selling its symbolic Osaka headquarters building to help finance its £46 billion ($60 billion) deal to acquire Irish drugmaker Shire Plc., sources close to the …
( read original story …)